AMA counts to 10 before voting drug shortages position

Unlike the many individual patients who report feeling powerless when they are unable to get drugs they need, doctors are plying their strength in numbers under the banner of the American Medical Association to catalyze a solution. They've voted their support for FDA and Congress to require contingency production plans of the makers of medically necessary drugs to ensure continuous supply. And members agreed to support financial incentives for drugmakers to continue production of scarce medicines, but only after ruling out the idea of financial penalties for those that don't promptly attempt to rectify shortages. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.